Company Description
MediPharm Labs Corp. is medicinal cannabis company, which engages in the pharmaceutical grade production of cannabis oil products. The company focuses on the downstream secondary extraction methodology, distillation, and cannabinoid isolation and purification. It supplies raw materials, formulations...
MediPharm Labs Corp. is medicinal cannabis company, which engages in the pharmaceutical grade production of cannabis oil products. The company focuses on the downstream secondary extraction methodology, distillation, and cannabinoid isolation and purification. It supplies raw materials, formulations, processing, and packaging for the creation of ready-to-sell derivative products. The company was founded by Patrick McCutcheon in 2015 and is headquartered in Barrie, Canada.
Valuation
P/E Current
72.83
P/E Ratio (without extraordinary items)
281.75
Price to Sales Ratio
4.02
Price to Book Ratio
3.86
Enterprise Value to EBITDA
47.29
Enterprise Value to Sales
3.80
Total Debt to Enterprise Value
0.02
Efficiency
Revenue/Employee
561,965.00
Income Per Employee
7,152.00
Receivables Turnover
7.61
Total Asset Turnover
1.22
Liquidity
Current Ratio
4.15
Quick Ratio
2.36
Cash Ratio
1.34
Profitability
Gross Margin
32.27
Operating Margin
6.08
Pretax Margin
5.22
Net Margin
1.27
Return on Assets
1.56
Return on Equity
2.07
Return on Total Capital
8.95
Return on Invested Capital
1.96
Capital Structure
Total Debt to Total Equity
8.04
Total Debt to Total Capital
7.44
Total Debt to Total Assets
6.27
Long-Term Debt to Equity
6.66
Long-Term Debt to Total Capital
6.16
Officers and Executives
| Name | Age | Officer Since | Title |
|---|---|---|---|
| Mr. Patrick McCutcheon | - | 2015 | Chairman, President & Chief Executive Officer |
| Mr. Keith Strachan | - | 2018 | Director & VP-Business Development |
| Mr. Robert Kwon | - | 2019 | Chief Financial Officer |
| Mr. Paul Hamelin | - | - | Vice President-Security & Information Technology |
| Dr. Tait R. Gale | - | 2019 | Manager-Research & Development |
Insider Actions
MarketWatch News on MEDIF
-
Medipharm Labs names Robert Kwon new CFO
- Tomi Kilgore
-
Your investing guide to cannabis 2.0
- Michael Brush
-
Cronos to supply bulk cannabis to MediPharm Labs' extraction facility to fulfill processing needs
- Tomi Kilgore
-
MediPharm Labs to supply Cronos with C$30 mln of private-label cannabis concentrate
- Tomi Kilgore
-
Cronos enters multi-year supply agreement with MediPharm Labs
- Tomi Kilgore
Other News on MEDIF
-
Stocks To Watch: Postmates, Walgreens And Cannabis Plays
- Seeking Alpha
-
MediPharm Labs Australia inks new supply deal with Vivo Cannabis
- Seeking Alpha
-
Full Steam Ahead At Cannabis Extractor Radient Technologies
- Seeking Alpha
-
MediPharm closes manufacturing deal with Avicanna
- Seeking Alpha
-
Success In Cannabis: The Valens Company
- Seeking Alpha
-
Weekly Cannabis Report: Natural Selection By COVID-19
- Seeking Alpha
-
Time To Regroup After The Cannabis Disaster
- Seeking Alpha
- Loading more headlines...
